Back

Impact of intravascular imaging guidance on the effects of aspirin-free strategy for percutaneous coronary intervention for acute coronary syndrome: a post-hoc analysis from the STOPDAPT-3 trial

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kensuke Takabayashi

Shiga University of Medical Science, Shiga (Japan)

5 More presentations in this session

Presentation thumbnail
Temporal trends in the use of P2Y12 inhibitors over 15 years and their impact on in-hospital bleeding and mortality among patients with acute myocardial infarction in Switzerland
Mr J. Loosli (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of routine cardiovascular medications on contrast induced nephropathy post percutaneous coronary intervention: a national experience
Doctor O. Alameen (Doha, QA)
Abstract Slides
Presentation thumbnail
Timing of P2Y12 inhibitor administration in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis
Doctor T. Theodoropoulou (Athens, GR)
Abstract Slides
Presentation thumbnail
Standard versus extended dual antiplatelet therapy after pci in acute coronary syndrome: a systematic review and meta-analysis
Mr A. Gasca (Cali, CO)
Abstract Slides
Presentation thumbnail
Early aspirin withdrawal to P2Y12 monotherapy after PCI for ACS: a systematic review and meta-analysis of randomized controlled trials
Professor M. Saffi (Porto Alegre, BR)
Abstract Slides

Access the full session

Session thumbnail
Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3
1 September 2025
thumbnail
Congress Presentation
Optimizing chronic total occlusion percutaneous coronary intervention: a comparative study of imaging-guided vs. conventional strategies
1 September 2025
thumbnail
Congress Presentation
Optimal timing of intervention in NSTE-ACS without pre-treatment
27 August 2021
thumbnail
Congress Presentation
Intravascular imaging in acute coronary syndromes.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources